Procalcitonin to guide duration of antibiotic therapy in intensive care patients: A randomized prospective controlled trial.
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Introduction: The development of resistance by bacterial species is a compelling issue to reconsider indications and administration of antibiotic treatment. Adequate indications and duration of therapy are particularly important for the use of highly potent substances in the intensive care setting. Until recently, no laboratory marker has been available to differentiate bacterial infection from viral or non-infectious inflammatory reaction; however, over the past years, procalcitonin (PCT) is the first among a large array of inflammatory variables that offers this possibility. The present study aimed to investigate the clinical usefulness of PCT for guiding antibiotic therapy in surgical intensive care patients. Methods: All patients requiring antibiotic therapy based on confirmed or highly suspected bacterial infections and at least two concomitant systemic inflammatory response syndrome criteria were eligible. Patients were randomly assigned to either a PCT-guided (study group) or a standard (control group) antibiotic regimen. Antibiotic therapy in the PCT-guided group was discontinued, if clinical signs and symptoms of infection improved and PCT decreased to <1 ng/ml or the PCT value was >1 ng/ml, but had dropped to 25 to 35% of the initial value over three days. In the control group antibiotic treatment was applied as standard regimen over eight days. Results: A total of 110 surgical intensive care patients receiving antibiotic therapy after confirmed or high-grade suspected infections were enrolled in this study. In 57 patients antibiotic therapy was guided by daily PCT and clinical assessment and adjusted accordingly. The control group comprised 53 patients with a standardized duration of antibiotic therapy over eight days. Demographic and clinical data were comparable in both groups. However, in the PCT group the duration of antibiotic therapy was significantly shorter than compared to controls (5.9 +/- 1.7 versus 7.9 +/- 0.5 days, P < 0.001) without negative effects on clinical outcome. Conclusions: Monitoring of PCT is a helpful tool for guiding antibiotic treatment in surgical intensive care patients. This may contribute to an optimized antibiotic regimen with beneficial effects on microbial resistance and costs in intensive care medicine. Annotation: Results were previously published in German in Anaesthesist 2008; 57: 571–577 (PMID: 18463831). Trial registration: ISRCTN10288268
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
(2013) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/103.1437-1588 · Cited by 11,796
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674 · cited 1×
“In addition, Sequential Organ Failure Assessment (SOFA) scores were calculated daily [16] to stratify and monitor disease severity.”
MethodKumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109 · cited 3×
“Accordingly, Kumar and colleagues [1] could show that the hospital mortality rate for patients with septic shock increased by about 7% per hour within the first six hours of delayed antibiotic administration.”
BackgroundChastre, J., Wolff, M., Fagon, J.-Y., Chevret, S., Thomas, F., Wermert, D., Clementi, E., Gonzalez, J., Jusserand, D., Asfar, P., et al. (2003) · JAMA · doi:10.1001/jama.290.19.2588 · Cited by 1,376
SINGH, N., ROGERS, P., ATWOOD, C. W., WAGENER, M. M., & YU, V. L. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9909095 · Cited by 1,032 · cited 3×
“Singh and colleagues [12] investigated intensive care patients with pneumonia and found that discontinuing antibiotic treatment after three days in the absence of a suspected infection did not worsen outcome.”
BackgroundIregui, M., Ward, S., Sherman, G., Fraser, V. J., & Kollef, M. H. (2002) · Chest · doi:10.1378/chest.122.1.262 · Cited by 956 · cited 1×
“A study from the USA was able to demonstrate that patients with ventilator-associated pneumonia who received antibiotic therapy only 24 hours after established diagnosis, exhibited a seven times higher mortality rate compared with patients started on adequate therapy earlier [21].”
ResultHARBARTH, S., HOLECKOVA, K., FROIDEVAUX, C., PITTET, D., RICOU, B., GRAU, G. E., VADAS, L., PUGIN, J., & the Geneva Sepsis Network (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.3.2009052 · Cited by 898
Cited by
Items 101–200 of 311
Jeon, K., Suh, J. K., Jang, E. J., Cho, S., Ryu, H. G., Na, S., Hong, S., Lee, H. J., Kim, J. Y., & Lee, S. (2019) · Journal of Korean Medical Science · doi:10.3346/jkms.2019.34.e110 · Cited by 57
Qu, R., Ji, Y., Ling, Y., Ye, C.-Y., Yang, S.-M., Liu, Y.-Y., Yang, R.-Y., Luo, Y.-F., & Guo, Z. (2012) · Saudi Medical Journal · doi:10.15537/1658-3175.5525 · Cited by 46
Tang, J., Long, W., Yan, L., Zhang, Y., Xie, J., Lu, G., & Yang, C. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-596 · Cited by 45
“Therefore, the serum PCT level can guide the use of antibiotics in respiratory tract infections to prevent the abuse of antibiotics in the intensive care unit [6-15].”
BackgroundJung, B., Molinari, N., Nasri, M., Hajjej, Z., Chanques, G., Jean‐Pierre, H., Panaro, F., & Jaber, S. (2013) · Critical Care · doi:10.1186/cc13082 · Cited by 47
“50 ng/ml or its decrease of at least 80% compared to its peak [5,9-11] allows withholding antibiotics earlier without affecting clinical outcome [12-15].”
Procalcitonin Levels Associate with Severity of Clostridium difficile Infection
Rao, K. K., Walk, S. T., Micić, D., Chenoweth, E., Deng, L., Gałecki, A. T., Jain, R., Trivedi, I., Yu, M., Santhosh, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058265 · Cited by 48
“Serum PCT is a biomarker with proven clinical utility in bacterial infections (studied in respiratory infections [17], sepsis [18,19], postoperative infections [20,21], and ventilator-associated pneumonia [22]) and this study, to our knowledge, is the first systematic investigation to show an association with severity…”
BackgroundBiomarkers of Infection: Are They Useful in the ICU?
Heilmann, E., Gregoriano, C., & Schüetz, P. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1696689 · Cited by 47
“[32] [33] [34] [35] [36] [37] [38] Indeed, PCT kinetics have shown prognostic implications, as decreasing values correlate with good outcomes, while increasing values correlate with adverse outcomes including mortality.”
BackgroundThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T.-A., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Journal of Intensive Care · doi:10.1186/s40560-025-00776-0 · Cited by 52
Emerging infection and sepsis biomarkers: will they change current therapies?
Jacobs, L., & Wong, H. R. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1222272 · Cited by 46
Role of procalcitonin in bacteremic patients and its potential use in predicting infection etiology
Bassetti, M., Russo, A., Righi, E., Dolso, E., Merelli, M., D’Aurizio, F., Sartor, A., & Curcio, F. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1562335 · Cited by 45
“Of interest, PCT can be an important tool also for prediction of outcome in patients hospitalized after major trauma, and its effect was also assessed in surgical patients at high risk of bacterial infection in the postoperative period [36].”
BackgroundMultiresistant bacteria and current therapy - the economical side of the story
Wilke, M. H. (2010) · European journal of medical research · doi:10.1186/2047-783x-15-12-571 · Cited by 41
Harrison, M., & Collins, C. D. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2014.60 · Cited by 47
Kubo, K., Sakuraya, M., Sugimoto, H., Takahashi, N., Kano, K., Yoshimura, J., Egi, M., & Kondo, Y. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006366 · Cited by 50
Sepsis Immunopathology: Perspectives of Monitoring and Modulation of the Immune Disturbances
Skirecki, T., Zielińska-Borkowska, U., Złotorowicz, M., & Hoser, G. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0166-1 · Cited by 41
Lipińska-Gediga, M., Mierzchała-Pasierb, M., & Durek, G. (2012) · Infection · doi:10.1007/s15010-011-0235-0 · Cited by 37
“It has been stated that PCT should be used as a diagnostic marker to monitor the course of severe sepsis and septic shock and antimicrobial therapy [15, 16].”
MethodZhang, Z., Smischney, N. J., Zhang, H., Poucke, S. V., Tsirigotis, P. D., Rello, J., Honoré, P. M., Kuan, W. S., Ray, J. J., Zhou, J., et al. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.08.03 · Cited by 41
“The risks of bias in included studies were mostly low or unclear (42-48).”
BackgroundBiomarkers for Sepsis: A Review with Special Attention to India
Nelson, G. E., Mave, V., & Gupta, A. (2014) · BioMed Research International · doi:10.1155/2014/264351 · Cited by 40
“The PRORATA trial, a multicenter, prospective, open-label, and randomized control trial including 621 patients in 8 ICUs in 6 hospitals followed these smaller studies and found a 23% reduction in antibiotic usage at day 28 [91].”
MethodArulkumaran, N., Khpal, M., Tam, K., Baheerathan, A., Corredor, C., & Singer, M. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004267 · Cited by 36
Daghmouri, M. A., Dudoignon, E., Chaouch, M. A., Bækgaard, J. S., Bouglé, A., Léone, M., Deniau, B., & Dépret, F. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.101880 · Cited by 39
Long, W., Li, L., Huang, G.-Z., Zhang, X., Yi-cui, Z., Tang, J., Zhang, Y., & Lu, G. (2014) · Critical Care · doi:10.1186/s13054-014-0471-7 · Cited by 36
“Overall, it has been shown that PCT might be feasible in guiding antibiotic treatment in patients with acute exacerbations of COPD [12] as well as in limiting treatment duration in patients with CAP [11] and severe infectious diseases in the intensive care unit [36-39].”
BackgroundBrodska, H. L., Malíčková, K., Valenta, J., Fabio, A., & Drábek, T. (2013) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2013.849357 · Cited by 36
Is Procalcitonin Useful in Pediatric Critical Care Patients?
Bobillo‐Pérez, S., Rodríguez‐Fanjul, J., & Jordán, I. (2018) · Biomarker Insights · doi:10.1177/1177271918792244 · Cited by 40
Weiss, C. H., Persell, S. D., Wunderink, R. G., & Baker, D. W. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-198 · Cited by 35
Sartelli, M., Catena, F., Ansaloni, L., Coccolini, F., Saverio, S. D., & Griffiths, E. A. (2015) · Surgical Infections · doi:10.1089/sur.2015.130 · Cited by 38
Li, H., Liu, Z., Zhao, S.-J., Zhang, D., Wang, S.-J., & Wang, Y. (2014) · Journal of International Medical Research · doi:10.1177/0300060514528483 · Cited by 33
“Thus, the ability to recognize bacterial infections in their early stages could guide the treatment needed, reduce unnecessary administration of antibiotics and control the development of drug-resistant strains.(1) Procalcitonin (PCT) and C-reactive protein (CRP) are biomarkers that have been studied for their ability…”
BackgroundS3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025
Brunkhorst, F. M., Adamzik, M., Axer, H., Bauer, M. W., Bode, C., Bone, H.-G., Brenner, T., Bucher, M., David, S., Dietrich, M., et al. (2025) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-025-01317-1 · Cited by 47
The role of serum procalcitonin in establishing the diagnosis and prognosis of pleural infection
Dixon, G., Lama-Lopez, A., Bintcliffe, O. J., Morley, A. J., Hooper, C. E., & Maskell, N. A. (2017) · Respiratory Research · doi:10.1186/s12931-017-0501-5 · Cited by 31
“Previous studies in nonpleural disease have used procalcitonin as a biomarker to decide when to stop antibiotic therapy [17, 18].”
BackgroundSerum procalcitonin in the diagnosis and management of intra-abdominal infections
Watkins, R., & Lemonovich, T. L. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.164 · Cited by 32
Huang, T., Huang, S.-S., Shyu, Y., Lee, C.-H., Jwo, S., Chen, P., & Chen, H.-Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090539 · Cited by 36
Procalcitonin: present and future
Liu, H. H., Guo, J., Geng, Y., & Su, L. (2015) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-015-1327-0 · Cited by 32
Sepsis Biomarkers. Value and Limitations
Vincent, J., & Teixeira, L. S. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201410-1895ed · Cited by 32
Wilke, M. H., Grube, R., & Bodmann, K. ‐. (2011) · European journal of medical research · doi:10.1186/2047-783x-16-12-543 · Cited by 32
“We collected data from several RCTs to determine possible favourable effects of PCT [9, 17-21].”
Antimicrobial Stewardship Using Biomarkers: Accumulating Evidence for the Critically Ill
Kyriazopoulou, E., & Giamarellos‐Bourboulis, E. J. (2022) · Antibiotics · doi:10.3390/antibiotics11030367 · Cited by 37
“[34] Sepsis Single-center—Germany Cessation if PCT < 1 ng/mL or ≥65% decrease for 3 serial days PCT: 57 SOC: 53 LOT: 5.”
BackgroundGoggs, R. A. N., Robbins, S. N., LaLonde‐Paul, D. F., & Menard, J. M. (2022) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16374 · Cited by 34
“23,26,48 The number of dogs necessary to distinguish peak biomarker concentrations from 20% peak results was estimated online (quantitativeskills.com/sisa/ calculations/samsize.htm) using data on C-C motif chemokine ligand 2 (CCL2), HMGB1 and cfDNA concentrations from prior studies.”
Guidelines for the Use of Procalcitonin for Rational Use of Antibiotics
Chaudhry, D., Sharma, A., Govil, D., Hadda, V., Jain, N., Tiwari, P., Samavedam, S., Dixit, S., Govindagoudar, M. B., Khilnani, G. C., et al. (2022) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24326 · Cited by 39
Duncan, E., Charani, E., Clarkson, J., Francis, J., Gillies, K., Grimshaw, J., Kern, W. V., Lorencatto, F., Marwick, C., McEwen, J., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa001 · Cited by 36
Procalcitonin-guided antibiotic therapy for septic patients in the surgical intensive care unit
Carr, J. A. (2015) · Journal of Intensive Care · doi:10.1186/s40560-015-0100-9 · Cited by 32
Bishop, B. M., Bon, J. J., Trienski, T. L., Pasquale, T. R., Martin, B. R., & File, T. M. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014520957 · Cited by 27
“1 days).(7) Nobre et al(8) found that using a PCT algorithm to guide antibiotic therapy in patients with sepsis resulted in a lower average number of days on antibiotics (6 vs 9.”
MethodMertz, D., Brooks, A. A., Irfan, N., & Sung, M. (2015) · Swiss Medical Weekly · doi:10.4414/smw.2015.14220 · Cited by 36
Keir, I., & Dickinson, A. E. (2015) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/vec.12272 · Cited by 26
Antibiotic Stewardship in Surgical Departments
Kourbeti, I. S., Kamiliou, A., & Samarkos, M. (2024) · Antibiotics · doi:10.3390/antibiotics13040329 · Cited by 31
“In patients with sepsis in surgical ICUs, PCT has been found to be a useful biomarker to safely reduce antibiotic consumption in this setting [11,97,98].”
BackgroundKopterides, P., & Tsangaris, I. (2012) · PubMed · Cited by 25
Recent Advances in Sepsis Research: Novel Biomarkers and Therapeutic Targets
Ivády, B., Beres, B. J., & Szabó, D. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796391598 · Cited by 26
Cabral, L., Afreixo, V. M. A., Meireles, R. P., Vaz, M., Chaves, C., Caetano, M., Almeida, L., & Paiva, J. A. (2018) · Burns & Trauma · doi:10.1186/s41038-018-0112-5 · Cited by 27
Extreme Procalcitonin Elevation without Proven Bacterial Infection Related to Amphetamine Abuse
Lovas, A., Ágoston, Z., Késmárky, K., Hankovszky, P., & Molnár, Z. (2014) · Case Reports in Critical Care · doi:10.1155/2014/179313 · Cited by 24
Gutiérrez-Pizarraya, A., León-García, M. D. C., Juan-Idígoras, R. D., & Garnacho‐Montero, J. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1932462 · Cited by 26
“Twenty-eight-day mortality was not reported in three studies [26,27,30].”
BackgroundMethodInfluentialGavazzi, G., Drevet, S., Debray, M., Bosson, J., Tidadini, F., Paccalin, M., de Wazières, B., Célarier, T., Bonnefoy, M., & Vitrat, V. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03658-4 · Cited by 27
Schüetz, P., Haubitz, S., & Müeller, B. (2012) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e328354b2c8 · Cited by 25
“[41] Single center, Germany, surgical ICU Suspected bacterial infections and >1 SIRS criteria 110 Hosp sta”
BackgroundProcalcitonin Test Availability: A Survey of Acute Care Hospitals in Massachusetts
Fisher, K. A., Landyn, V., Lindenauer, P. K., & Walkey, A. J. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201704-306rl · Cited by 24
Streamlining antibiotic therapy with procalcitonin protocols: consensus and controversies
Haubitz, S., Müeller, B., & Schüetz, P. (2013) · Expert Review of Respiratory Medicine · doi:10.1586/ers.13.6 · Cited by 24
Use of evidence-based recommendations in an antibiotic care bundle for the intensive care unit
Mutters, N. T., Angelis, G. D., Restuccia, G., Muzio, F. D., Schouten, J. A., Hulscher, M., Antonelli, M. M., & Tacconelli, E. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.06.020 · Cited by 23
Ali, W. A., Bazan, N. S., Elberry, A. A., & Hussein, R. R. S. (2021) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-020-02494-y · Cited by 27
Procalcitonin-guided antibiotic therapy in critically ill adults: a meta-analysis
Zhang, T., Wang, Y., Yang, Q., & Dong, Y. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2622-3 · Cited by 25
Wongsurakiat, P., & Tulatamakit, S. (2018) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466618760134 · Cited by 24
Biomarkers as a guide for antimicrobial therapy
Reinhart, K., & Hartog, C. S. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.11.009 · Cited by 24
“In a smaller single-centre study [15], Hochreiter et al.”
BackgroundOdermatt, J., Friedli, N., Kutz, A., Briel, M., Bucher, H. C., Christ‐Crain, M., Burkhardt, O., Welte, T., Müeller, B., & Schüetz, P. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0252 · Cited by 22
Michel, C. S., Teschner, D., Wagner, E. M., Theobald, M., & Radsak, M. P. (2017) · Annals of Hematology · doi:10.1007/s00277-017-3128-1 · Cited by 21
Bilgili, B., Haliloğlu, M., Aslan, M. S., Sayan, İ., Kasapoğlu, U. S., & Cinel, İ. (2017) · Türk anesteziyoloji ve reanimasyon derneği dergisi · doi:10.5152/tjar.2017.88965 · Cited by 22
“It is used in the determination of the duration of antibiotic treatment and in making the decision of antibiotic cessation in patients with sepsis (9).”
MethodGUIDANCE FOR IMPLEMENTING AN ANTIMICROBIAL STEWARDSHIP PROGRAM IN JAPAN
8学会合同抗微生物薬適正使用推進検討委員会 (2017) · Kansenshogaku zasshi · doi:10.11150/kansenshogakuzasshi.91.709 · Cited by 24
Kim, C.-J. (2022) · Infection and Chemotherapy · doi:10.3947/ic.2022.0172 · Cited by 20
“Eight evaluated whether to discontinue antibiotics using the PCT algorithm [163-170].”
Gutiérrez‐Gutiérrez, B., Morales, I., Pérez-Galera, S. I., Riejos, P. F., Retamar, P., de Cueto, M., Pascual, Á., & Rodríguez‐Baño, J. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.07.019 · Cited by 19
Amin, D. N., Pruitt, J. C., & Schüetz, P. (2012) · Anaesthesia and Intensive Care · doi:10.1177/0310057x1204000502 · Cited by 19
Beye, F., Vigneron, C., Dargent, A., Prin, S., Andreu, P., Large, A., Quenot, J., Bador, J., Bruyère, R., & Charles, P. (2019) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.05.022 · Cited by 22
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Acute Medicine & Surgery · doi:10.1002/ams2.70037 · Cited by 27
Management of Intra-Abdominal Infections: The Role of Procalcitonin
Tian, B. W. C. A., Agnoletti, V., Ansaloni, L., Coccolini, F., Bravi, F., Sartelli, M., Vallicelli, C., & Catena, F. (2023) · Antibiotics · doi:10.3390/antibiotics12091406 · Cited by 25
“[10] conducted a trial to analyze the role of PCT in patients in the surgical intensive care unit (SICU), who were receiving antibiotics.”
BackgroundMethodInfluentialProcalcitonin Guided Antibiotic Stewardship
Kiya, G. T., Asefa, E. T., Abebe, G., & Mekonnen, Z. (2024) · Biomarker Insights · doi:10.1177/11772719241298197 · Cited by 25
Biomarkers for risk stratification and antibiotic stewardship in elderly patients
Falcone, M., Bauer, M. W., Ferrer, R., Gavazzi, G., del Castillo, J. M. G., Pilotto, A., & Schüetz, P. (2023) · Aging Clinical and Experimental Research · doi:10.1007/s40520-023-02388-w · Cited by 20
Longitudinal changes in procalcitonin in a heterogeneous group of critically ill patients*
Reynolds, S., Shorr, A. F., Muscedere, J., Jiang, X., & Heyland, D. K. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31825b89cc · Cited by 17
Ruiz‐Rodríguez, J. C., Caballero, J., Ruiz-Sanmartín, A., Ribas, V. J., Pérez, M., Jl, B., & Rello, J. (2012) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2012.10.003 · Cited by 17
Host Response Biomarkers in Sepsis: The Role of Procalcitonin
Vincent, J., Nuffelen, M. V., & Lelubre, C. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1776-1_16 · Cited by 17
Paul, R. M. (2018) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2018.07.012 · Cited by 22
Shorr, A. F., Janes, J., Artigas, A., Tenhunen, J. J., Wyncoll, D. L. A., Mercier, E., François, B., Vincent, J., Vangerow, B., Heiselman, D., et al. (2010) · Critical Care · doi:10.1186/cc9382 · Cited by 16
The role of biomarkers in low respiratory tract infections
Blasi, F., Bocchino, M., Marco, F. D., Richeldi, L., & Aliberti, S. (2012) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2012.05.002 · Cited by 19
Lavrentieva, A., Kontou, P., Soulountsi, V., Kioumis, J., Chrysou, O., & Bitzani, M. (2015) · Europe PMC (PubMed Central) · Cited by 16
Ren, H., Ren, J., Hu, Q., Wang, G., Gu, G., Li, G., Wu, X., Hong, Z., & Li, J. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2016.08.055 · Cited by 16
“It has been shown to transiently rise after major surgery and gradually falls back to normal level along with the control of infection,(9-11) whereas CRP and the WBC count increase slowly and peak 36 h after endotoxin stimulus.(6) They can remain elevated on the PODs without an underlying infection.”
BackgroundChomba, R., Moeng, M. S., & Lowman, W. (2020) · South African Journal of Surgery · doi:10.17159/2078-5151/2020/v58n3a3341 · Cited by 19
Elnajdy, D., & El‐Dahiyat, F. (2022) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2022.2037701 · Cited by 15
An Audit of Repeat Testing at an Academic Medical Center
Hueth, K. D., Jackson, B. R., & Schmidt, R. L. (2018) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqy020 · Cited by 16
Use of a Procalcitonin-guided Antibiotic Treatment Algorithm in the Pediatric Intensive Care Unit
Katz, S. E., Crook, J. L., Gillon, J., Stanford, J. E., Wang, L. A., Colby, J. M., & Banerjee, R. (2020) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002986 · Cited by 16
from the PROCALCIVIR and BPCTrea study group, Daubin, C., Fournel, F., Thiollière, F., Daviaud, F., Ramakers, M., Polito, A., Flocard, B., Valette, X., du Cheyron, D., et al. (2021) · Annals of Intensive Care · doi:10.1186/s13613-021-00816-6 · Cited by 19
De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock
Silva, B. N. G., Andriolo, R. B., Atallah, Á. N., & Salomão, R. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007934.pub2 · Cited by 23
Effects of a comprehensive antimicrobial stewardship program in a surgical intensive care unit
Kim, S., Yoon, J. G., Park, H. J., Won, H., Ryoo, S. S., Choi, E., Park, E., Huh, K., & Park, C.-M. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.02.082 · Cited by 16
Role of procalcitonin in guiding antibiotic therapy
Fazili, T. N., Endy, T. P., Javaid, W., & Maskey, M. K. (2012) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp110736 · Cited by 16
De-escalating Antibiotic Use in the Inpatient Setting: Strategies, Controversies, and Challenges
Markley, J. D., Bernard, S., Bearman, G. M., & Stevens, M. (2017) · Current Infectious Disease Reports · doi:10.1007/s11908-017-0575-8 · Cited by 19
Rafiq, S., Shi, C., Ghosal, S., Dark, P. M., Felton, T., Kontopantelis, E., & Dumville, J. C. (2026) · Anaesthesia · doi:10.1111/anae.70109 · Cited by 17
“Sepsis de fi nitions varied, with most studies using Sepsis-1 [43 – 45, 47, 50]; Sepsis-2 [49, 51]; or Sepsis-3 criteria [14, 56 – 58 , In studies comparing PCT-or CRP-guided care with standard care, antibiotic discontinuation in the control group was guided by various approaches: international,…”
Eder, J., Hlavin, G., Haushofer, A. C., Trubert-Exinger, D., & Trautinger, F. (2012) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2011.07858.x · Cited by 13
Lam, S. W., Bauer, S. R., & Duggal, A. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.10.017 · Cited by 14
Procalcitonin-guided antibiotic treatment in critically ill patients
Höhn, A., Heising, B., Schütte, J.-K., Schroeder, O., & Schröder, S. (2016) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-016-1458-4 · Cited by 14
“However, both of the PCT studies in surgical ICU patients [30, 33] and two of the RCTs in a mixed ICU population [15, 31] did not exclusively Fig.”
BackgroundResultInfluentialWhen once is not enough – further evidence of procalcitonin-guided antibiotic stewardship
Harbarth, S., Albrich, W. C., & Müller, B. (2009) · Critical Care · doi:10.1186/cc7935 · Cited by 15
“In their article, Hochreiter and colleagues published the English translation of another randomized clinical trial of critically ill patients with different types of infections [1], confirming the study findings by Nobre and colleagues [10].”
BackgroundResultThe Predictive Role of Procalcitonin On the Treatment of Intra-Abdominal Infections
Mahmutaj, D., Krasniqi, S., Braha, B., Limani, D., & Neziri, B. (2017) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2017.194 · Cited by 12
Wunderink, R. G., Diederich, E., Caramez, M. P., Donnelly, H. K., Norwood, S. D., Kho, A., & Reed, K. D. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31824fc027 · Cited by 12
A meta-analysis to assess usefulness of procalcitonin-guided antibiotic usage for decision making
Shafiq, N., Gautam, V., Pandey, A. K., Kaur, N., Garg, S., Negi, H., Kaur, S., Ray, P., & Malhotra, S. (2017) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_613_15 · Cited by 12
Infection management in patients with sepsis and septic shock in resource-limited settings
Thwaites, L., Lundeg, G., & Dondorp, A. M. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4547-5 · Cited by 12
Caffarini, E., DeMott, J. M., Patel, G. P., & Lat, I. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02007-16 · Cited by 13
Antimicrobial stewardship: attempting to preserve a strategic resource
Schooneveld, T. C. V. (2011) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.3402/jchimp.v1i2.7209 · Cited by 11
Aßfalg, V., Wolf, P., Reim, D., Hüser, N., Hellbrügge, G., Matevossian, E., Frieß, H., Holzmann, B., Emmanuel, K., & Novotny, A. (2015) · Surgery Today · doi:10.1007/s00595-015-1226-z · Cited by 10
“PCT kinetics could be correlated with the appropriateness of antibiotic therapy [29–31], but PCT elevation and diagnosis accuracy have been reported to be lower in patients with preceding septic events than in those with a first episode of infection [32].”
MethodResultBiomarkers in sepsis: can they help improve patient outcome?
Kyriazopoulou, E., Poulakou, G., & Giamarellos‐Bourboulis, E. J. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000707 · Cited by 11
“LRTI Sepsis Rule to start Rule to stop Mix rule [7,9] H H [15] H H [13,17] H H [14] H H [11,12] H H [19] H H [10] H H [16,20,22,23] H H [21] H H [17] H H LRTI, lower respiratory tract infection.”
BackgroundHeilmann, E., Gregoriano, C., Annane, D., Reinhart, K., Bouadma, L., Wolff, M., Chastre, J. E., Luyt, C. E., Tubach, F., Branche, A. R., et al. (2021) · Age and Ageing · doi:10.1093/ageing/afab078 · Cited by 15
Ammar, A. A., Lam, S. W., Duggal, A., Neuner, E. A., Bass, S. N., Guzmán, J. A., Wang, X., Han, X., & Bauer, S. R. (2016) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1887 · Cited by 10
To which extent can we decrease antibiotic duration in critically ill patients?
Garnacho‐Montero, J., Arenzana, Á., Waele, J. J. D., & Kollef, M. H. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1369879 · Cited by 11
Role of biomarkers in antimicrobial stewardship: physicians’ perspectives
Seok, H., & Park, D. W. (2024) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2023.558 · Cited by 13
“An RCT conducted in Germany evaluated the effectiveness of PCT-guided antibiotic therapy in patients with sepsis admitted to surgical ICUs [56].”
Metadata
- Authors
- Hochreiter, M., Köhler, T., Schweiger, A. M., Keck, F. S., Bein, B., von Spiegel, T., & Schroeder, S.
- Affiliations
- Westküstenkliniken Brunsbüttel und Heide gGmbH (DE)
- University Hospital Schleswig-Holstein (DE)
- Venue
- Critical Care
- Published
- 2009-06-03
- Volume
- 13
- Issue
- 3
- Pages
- R83-R83
- ISSN
- 1364-8535 (ISSN-L)
- PMC
- PMC2717450
- OpenAlex
- W2109928541
- Semantic Scholar
- 269d1d25f4ebc2ac9fd79ee6e50e38b8ebd7138d
- Cited by
- 315
- References
- 29
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 10 · 2023: 13 · 2022: 10 · 2021: 22 · 2020: 9 · 2019: 16 · 2018: 21 · 2017: 32 · 2016: 18 · 2015: 23 · 2014: 18 · 2013: 28 · 2012: 32
- FWCI
- 17.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Critical Care (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Keywords
- procalcitonin, antibiotic duration, antibiotic stewardship, surgical intensive care patients, bacterial infection, systemic inflammatory response syndrome, antibiotic de-escalation, antimicrobial resistance, inflammatory markers
- MeSH terms
- Aged, Anti-Bacterial Agents, Calcitonin, Diagnosis, Differential, Female, Humans, Male, Postoperative Complications, Prospective Studies, Protein Precursors, Biomarkers, Calcitonin Gene-Related Peptide, Drug Monitoring, Systemic Inflammatory Response Syndrome, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.